News

CARsgen® U.S. Clinical Holds Lifted by FDA

CARsgen Therapeutics

SHANGHAI,Nov. 1,2024-- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK),a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors,

Home Previous 201 202 203 204 205 206 207 Next Tail

10 Items Per Page (Page 204 / 562) Total 5614 Items

©Copyright 2009-2020 Yahoo Perspective   cryydr@163.com   Contact Us   SiteMap